GenVec Inc (fka GNVC)

[north40000]

XON takeout of GNVC in all share deal + CVRs.

http://finance.yahoo.com/news/intrexon-acquire-genvec-expand-industry-140000103.html

…GenVec stockholders will receive 0.297 of a share of Intrexon Common Stock in exchange for each share of GenVec common stock. This exchange ratio represents $7.00 per share of GenVec's common stock based on Intrexon's 5-day volume weighted average price as of January 23, 2017 [but only $6.56/sh based on XON’s latest price—see below].

GenVec stockholders will also receive a right to contingent consideration equal to 50% of any milestone or royalty payments received within 36 months after the closing of the transaction under GenVec's Research Collaboration and License Agreement with Novartis.